XTL Biopharmaceuticals Ltd. — Earnings Release 2014

Jun 2, 2014

_________ false

C002��� �� �� ������������� ��"�2PublicX T L BIOPHARMACEUTICALS LTD4313Corporation no: 520039470Stock Exchange/Market: -11996380Medinat hayehudim st 85 , Herzliya 4614001 , ,Tel: 09-9557080 , Fax: 09-9519727E.mail address: ir@xtlbio.comReported via MAGNA: 02/06/2014              Time of broadcast: 16:50 16:43:06

Company site:		www.xtlbio.com

Reference: 2014-02-083013

Israel Securities Authority		Tel Aviv Stock Exchange
www.isa.gov.il		www.tase.co.il

Immediate ReportRegulation 4 of the Securities Regulations, (Periodic and Immediate Reports of Foreign Corporation) 5761-2000

The corporation is a foreign private issuer as defined by U.S. Securities Laws.
Attached hereto is a report on earning release for the quarter ended on March 31, 2014
6-2-14_XTL_Bio_Q1_2014_Earnings_Release_isa.pdf

References of previous documents relating to this matter(the reference does not constitute incorporation by reference):
Previous names of reporting entity: XENOGRAFT TECHNOLOGIES LTD
Date of revision of form structure: 14/05/2014
- - -
Name of the Signatory: : Kntor Ronen , Position of Signatory in the reporting corporation: Legal Adviser , Name of Employer Company: .
Abba Hillel Silver Rd Telephone: 03-6133371 , Facsimile: 03-6133372 , E-mail: rkantor@kantor-law.com 2